Lymphatic mapping and sentinel node biopsy of operable breast cancer

World Journal of Surgery

Volumn 24, Issue 10, 2000, Pages 1220-1226

  Rodier, Jean François ^a   Routiot, Thierry ^a   Mignotte, Hervé ^b   Janser, Jean Claude ^a   Bremond, Alain ^b   David, Eric ^a   Barlier, Catherine ^a   Ghnassia, Jean Pierre ^a   Treilleux, Isabelle ^b   Chassagne, Catherine ^b   Velten, Michel ^a  

^a Paul Strauss Comprehensive Cancer Center   (France)

^b CENTRE LÉON BÉRARD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER INVASION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EVALUATION; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; LYMPH NODE BIOPSY; MAJOR CLINICAL STUDY; PREDICTION; PROSPECTIVE STUDY; RELIABILITY; REPRODUCIBILITY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; LYMPH NODES; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENTINEL LYMPH NODE BIOPSY;

EID: 0033736432     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002680010240     Document Type: Article

References (50)

1. Lymphatic mapping and sentinel lymphadenectomy for breast cancer
2. An approach for the treatment of penile carcinoma
3. Management of early stage melanoma by intraoperative lymphatic mapping and selective lymphadenectom
4. Technical details of intraoperative lymphatic mapping for early stage melanoma
5. Use of primary breast carcinoma characteristics to predict lymph node metastases
6. Use of primary carcinoma characteristics to predict lymph node metastases: Reply
7. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma
8. Is axillary dissection necessary for T1 carcinoma of the breast?
9. Reappraisal of the role of axillary lymph node dissection in the conservative treatment of breast cancer
10. The role of axillary dissection in mammographically detected carcinoma
11. Axillary lymph node dissection: Is it required in T1a breast cancer
12. Early stage breast cancer: An approach to treatment
13. Enhancing the accuracy for predictors of axillary nodal metastasis in T1 carcinoma of the breast: Role of selective biopsy with lymphatic mapping
14. Incidence and predictors of axillary metastasis in T1 carcinoma of the breast
15. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma
16. Sentinel axillary lymphadenectomy with intraoperative lymphatic mapping in breast cancer
17. Surgical technical details improving sentinel node identification in breast cancer
18. Individualisation du ganglion axillaire sentinelle par colorant lymphotrope dans les cancers du sein: Etude de faisabilite a propos de 128 cas
19. Intraoperative lymphatic mapping and sentinel node biopsy in breast cancer
20. Assessment of morbidity from complete axillary dissection
21. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer
22. Sentinel lymphadenectomy: A technique to eliminate axillary dissection in node-negative breast cancer
23. Lymphatic mapping and sentinel node biopsy in breast cancer
24. Sentinel lymphadenectomy: A new axillary staging procedure for primary breast carcinoma
25. Sentinel lymphadenectomy in primary breast carcinoma: An alternative to routine axillary dissection
26. Improved axillary staging of breast cancer with sentinel lymphadenectomy
27. Sentinel lymphadenectomy in breast cancer
28. Identificatie van de Schildwachtklier bij patienten met mammacarcinoom
29. Intradermal blue dye to identify lymph node in breast cancer
30. Sentinel lymph node biopsy in breast cancer: Initial experience at Memorial Sloan-Kettering Cancer Center
31. Sentinel lymph node localization in early breast cancer
32. The sentinel node biopsy in breast cancer: A multicenter validation study
33. Sentinel-node biopsy in breast cancer
34. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes
35. Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection
36. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast-cancer
37. Gamma-probe guided localization of lymph nodes
38. Sentinel node biopsy in breast cancer using Tc 99m-colloidal albumin
39. Optimization of axillary lymphoscintigraphy to detect the sentinel node in breast cancer
40. Technetium-99m-sestamibi uptake in axillary lymph node metastases in breast cancer patients
41. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer
42. Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabeled dextran
43. Can sentinel node biopsy avoid axillary dissection in clinically node-negative breast cancer patients?
44. A rapid immunostaining method for frozen sections
45. Sentinel lymph node biopsy for staging breast cancer
46. Lymphatic mapping and sentinel node biopsy in breast cancer
47. Cancer du sein: Une approche conservatrice de la region axillaire pour une meilleure evaluation pronostique
48. Sentinel lymph node biopsy for breast cancer: Not yet the standard of care
49. Sentinel lymph node biopsy
50. Sentinel node biopsy: A valid Selection criterion?